NCT00719680View on ClinicalTrials.gov

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Primary Immune Deficiency
Interventions
BIOLOGICAL

IgPro20

Trial Locations (4)

33408

Contact CSL Behring for facility details, North Palm Beach

46202

Contact CSL Behring for facility details, Indianapolis

75230

Contact CSL Behring for facility details, Dallas

80112

Contact CSL Behring for facility details, Centennial

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY